A multicenter, single arm, open-label trial to evaluate efficacy and safety of oral, twice daily iptacopan in adult PNH patients who have Hb>10 g/dL in response to anti-C5 antibody and switch and iptacopanadult PNH patients who have Hb >=10 g/dL in respo

Project: Research project